These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16424059)

  • 1. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
    Wang G; Platt-Higgins A; Carroll J; de Silva Rudland S; Winstanley J; Barraclough R; Rudland PS
    Cancer Res; 2006 Jan; 66(2):1199-207. PubMed ID: 16424059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.
    de Silva Rudland S; Martin L; Roshanlall C; Winstanley J; Leinster S; Platt-Higgins A; Carroll J; West C; Barraclough R; Rudland P
    Clin Cancer Res; 2006 Feb; 12(4):1192-200. PubMed ID: 16489073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
    Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
    Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
    Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
    Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
    Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
    Oates AJ; Barraclough R; Rudland PS
    Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.
    Zakaria R; Platt-Higgins A; Rathi N; Crooks D; Brodbelt A; Chavredakis E; Lawson D; Jenkinson MD; Rudland PS
    Br J Cancer; 2016 May; 114(10):1101-8. PubMed ID: 27100728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal region of S100A4 is important for its metastasis-inducing properties.
    Zhang S; Wang G; Liu D; Bao Z; Fernig DG; Rudland PS; Barraclough R
    Oncogene; 2005 Jun; 24(27):4401-11. PubMed ID: 15856021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
    Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
    Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma S100P level as a novel prognostic marker of metastatic breast cancer.
    Peng C; Chen H; Wallwiener M; Modugno C; Cuk K; Madhavan D; Trumpp A; Heil J; Marmé F; Nees J; Riethdorf S; Schott S; Sohn C; Pantel K; Schneeweiss A; Yang R; Burwinkel B
    Breast Cancer Res Treat; 2016 Jun; 157(2):329-338. PubMed ID: 27146585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.
    Lloyd BH; Platt-Higgins A; Rudland PS; Barraclough R
    Oncogene; 1998 Jul; 17(4):465-73. PubMed ID: 9696040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis.
    Ismail TM; Gross SR; Lancaster T; Rudland PS; Barraclough R
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
    Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
    Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1.
    Wang G; Rudland PS; White MR; Barraclough R
    J Biol Chem; 2000 Apr; 275(15):11141-6. PubMed ID: 10753920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer.
    Chung L; Phillips L; Lin MZ; Moore K; Marsh DJ; Boyle FM; Baxter RC
    Cancer Lett; 2015 Nov; 368(1):64-70. PubMed ID: 26276712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer.
    Matsumoto K; Irie A; Satoh T; Ishii J; Iwabuchi K; Iwamura M; Egawa S; Baba S
    Urology; 2007 Sep; 70(3):602-7. PubMed ID: 17688917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast.
    Schor AP; Carvalho FM; Kemp C; Silva ID; Russo J
    Oncol Rep; 2006 Jan; 15(1):3-6. PubMed ID: 16328027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.